Home » Metro » Health and Science
City team’s breakthrough in blood-clotting research
Print Edition
A BREAKTHROUGH by Shanghai scientists offers the possibility of improved drugs to treat cardiovascular disease and other blood-clotting conditions.
A team from the Shanghai Institute of Materia Medica, the Chinese Academy of Sciences, has decoded the structure of P2Y12R protein, which is responsible for the formation of blood-clotting protein.
Thrombus — or blood-clotting — includes conditions such as strokes and coronary heart disease. In China, 2 million people suffer strokes each year.
The global market for thrombus treatments is worth billions of US dollars in annual sales.
“A detailed three-dimensional structure is important to study the working mechanism from a molecular level and make more effective and less risky drugs,” said Zhao Qiang, the program’s leading researcher.
The team’s findings are published in the journal “Nature.”
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
